INSYS Therapeutics, Inc. (NASDAQ: INSY), announced om November 1, 2018 that a pharmacokinetic (PK) study (INS012-18-119) of its proprietary intranasal naloxone spray formulations for the treatment of opioid overdose showed a distinctive PK profile compared to the current standards of intramuscular (IM) and intravenous (IV) administration of naloxone.
Author Archive: AZBio
Honoring Our AZBio Veterans – Veterans Day 2018
Each Year AZBio extends an opportunity to all member companies to tell us about the veterans on their team. This video is our tribute to them and to all who have served. Continue reading
Jill German named Head of Roche Tissue Diagnostics
Jill German has been named Head of Roche Tissue Diagnostics, an innovator of tissue-based diagnostic solutions for patients worldwide. Located in Tucson, Arizona, Roche Tissue Diagnostics is the leading global supplier of cancer diagnostic systems to the pathology market, providing more than 250 cancer tests and associated instruments. She succeeds Ann Costello, who has taken on a new leadership position with Roche in Rotkreuz, Switzerland.Continue reading
Symple Surgical Secures NIH Grant & Angel Investment
One of Moonshot at NACET’s first business incubator and accelerator clients, Symple Surgical, Inc. (SSI), is graduating from the entrepreneurial program and relocating to Flagstaff Airport Airpark after securing significant grants and angel investment funds.Continue reading
City of Hope, TGen announce letter of intent to build cell therapy manufacturing facility in Phoenix
The move would enable the organizations to meet a demand for clinical cell therapies that is expected to grow 42 percent annually over the next decadeContinue reading
UA Professor Receives Grant for Innovative Research in Preventing Heart Failure
NIH grant will allow Taben Hale, PhD, to study cardiac fibroblasts.
A University of Arizona College of Medicine – Phoenix researcher has received a $393,493 grant from the National Institutes of Health to further her research in reducing the risk of heart failure in patients with high blood pressure.Continue reading
C-Path, CHDI and CDISC announce therapeutic area user guide for Huntington’s Disease
The Huntington’s Disease Regulatory Science Consortium (HD-RSC), launched in March 2018 by the Critical Path Institute (C-Path) and CHDI Foundation, today, along with the Clinical Data Interchange Standards Consortium (CDISC), announce the open availability of a newly developed Huntington’s Disease Therapeutic Area User Guide
Continue reading
HTG Molecular Appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President
HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the appointment of Maureen T. Cronin, Ph.D., as the Company’s Chief Scientific Officer and Senior Vice President as of November 16, 2018. Dr. Cronin is a veteran biotechnology, translational science and diagnostic executive.Continue reading